i
Estimating vaccine effectiveness in preventing laboratory‐confirmed influenza in outpatient settings in South Africa, 2015
-
Published Date:
Dec 20 2016
Publisher's site:Source:Influenza Other Respir Viruses. 11(2):177-181. -
Alternative Title:Influenza Other Respir Viruses
-
Personal Author:
-
Description:Trivalent seasonal influenza vaccine effectiveness during the 2015 season in South Africa was assessed using a test-negative case control study design. Influenza A(H1N1)pdm09 was the dominant circulating strain. Overall influenza vaccine coverage was 3.2% (29/899). The vaccine effectiveness estimate, against any influenza virus infection, adjusted for age, underlying conditions and timing within season was 46.2% (95% CI: -23.5 to 76.5), and 53.6% (95% CI: -62.6 to 80.3) against influenza A(H1N1)pdm09.
-
Subject:
-
Pubmed ID:27865064
-
Pubmed Central ID:PMC5304569
-
Document Type:
-
Collection(s):
-
Main Document Checksum:
-
File Type:
-
Supporting Files:
image/gif 
image/jpeg 
image/gif 
image/jpeg 
application/octet-stream
[PDF-319.87 KB]
Details:
No Related Documents.
You May Also Like:
-
[PDF - 302.64 KB]
Published Date:Source:Description:File Type:[PDF - 302.64 KB]
File Type:[PDF - 302.64 KB]
[PDF - 1.86 MB]
Published Date:Source:Description:File Type:[PDF - 1.86 MB]
File Type:[PDF - 1.86 MB]
[PDF - 604.82 KB]
Published Date:Source:Description:File Type:[PDF - 604.82 KB]
File Type:[PDF - 604.82 KB]
[PDF - 334.33 KB]
Published Date:Source:Description:File Type:[PDF - 334.33 KB]
File Type:[PDF - 334.33 KB]
[PDF - 237.92 KB]
Published Date:Source:Description:File Type:[PDF - 237.92 KB]
File Type:[PDF - 237.92 KB]
Have Questions?
Visit CDC Info
Email
CDC-INFO
Open 24/7
CDC INFORMATION
CONNECT WITH CDC
